Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average, structural decline.
Left:
||||
Year-over-year net income growth rate
Latest
-13.55%
↑ 74% above average
Average (9y)
-51.23%
Historical baseline
Range
High:28.27%
Low:-164.41%
CAGR
-12.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | -13.55% |
| 2023 | -83.05% |
| 2022 | -63.54% |
| 2021 | 28.27% |
| 2020 | -164.41% |
| 2019 | -28.04% |
| 2018 | -23.35% |
| 2017 | -109.18% |
| 2016 | -11.88% |
| 2015 | -43.57% |